Pharmaceutical Affairs Act Article 66

For publishing or broadcasting medicament advertisements, pharmaceutical firms shall, before publishing or broadcasting, submit all texts, drawings, or pictures constituting an advertisement to the central or municipal competent health authority for approval and shall forward the approval to mass media enterprises for verification. If the competent health authority who issues the approval discovers the content of the medicament advertisement or the way it is displayed may be harmful or possibly endangering to the health of the public, it shall issue an order for an immediate stop of the display and for a remedy to the situation within a given time; failure to comply shall be subject to revoking the approval.No modifications or alterations to the approved contents are allowed during the term being permitted to be published or broadcast.No mass media enterprise shall publish or broadcast any medicament advertisement that has not been approved, has been different from the approved particular, has been withdrawn, or has not yet made amendments in time as ordered by the central or municipal competent health authority.A mass media enterprise being commissioned by a principal to publish or broadcast an advertisement shall maintain the particulars of its principal, including its name (corporate or group name), identification number, business license number, domicile (firm or business office) and telephone number, etc., for six months from the date of such advertisement. It shall not evade, impede, or refuse any request by the competent authority for such particulars.